Literature DB >> 29939338

Disconnected and Hyperactive: A Replication of Sensorimotor Cortex Abnormalities in Patients With Schizophrenia During Proactive Response Inhibition.

Christopher J Wertz1, Faith M Hanlon1, Nicholas A Shaff1, Andrew B Dodd1, Juan Bustillo2, Shannon F Stromberg2, Denise S Lin2, Swala Abrams2, Ronald A Yeo3, Jingyu Liu1, Vince Calhoun1,4, Andrew R Mayer1,2,3,5.   

Abstract

Inhibitory failure represents a core dysfunction in patients with schizophrenia (SP), which has predominantly been tested in the literature using reactive (ie, altering behavior after a stimulus) rather than proactive (ie, purposefully changing behavior before a stimulus) response inhibition tasks. The current study replicates/extends our previous findings of SP exhibiting sensorimotor cortex (SMC) hyperactivity and connectivity abnormalities in independent samples of patients and controls. Specifically, 49 clinically well-characterized SP and 54 matched healthy controls (HC) performed a proactive response inhibition task while undergoing functional magnetic resonance imaging and resting-state data collection. Results indicated that the majority of SP (84%) and HC (88%) successfully inhibited all overt motor responses following a cue, eliminating behavioral confounds frequently present in this population. Observations of left SMC hyperactivity during proactive response inhibition, reduced cortical connectivity with left SMC, and increased connectivity between left SMC and ventrolateral thalamus were replicated for SP relative to HC in the current study. Similarly, negative symptoms (eg, motor retardation) were again associated with SMC functional and connectivity abnormalities. In contrast, findings of a negative blood oxygenation level-dependent response in the SMC of HC did not replicate. Collectively, current and previous findings suggest that SMC connectivity abnormalities may be more robust relative to evoked hemodynamic signals during proactive response inhibition. In addition, there is strong support that these SMC abnormalities are a key component of SP pathology, along with dysfunction within other sensory cortices, and may be associated with certain clinical deficits such as negative symptoms.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  connectivity; fMRI; motor; response inhibition

Mesh:

Year:  2019        PMID: 29939338      PMCID: PMC6483571          DOI: 10.1093/schbul/sby086

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  55 in total

1.  fMRI evidence that the neural basis of response inhibition is task-dependent.

Authors:  Stewart H Mostofsky; Joanna G B Schafer; Michael T Abrams; Melissa C Goldberg; Abigail A Flower; Avery Boyce; Susan M Courtney; Vince D Calhoun; Michael A Kraut; Martha B Denckla; James J Pekar
Journal:  Brain Res Cogn Brain Res       Date:  2003-07

2.  Stop-signal response inhibition in schizophrenia: behavioural, event-related potential and functional neuroimaging data.

Authors:  Matthew Edward Hughes; William Ross Fulham; Patrick James Johnston; Patricia Therese Michie
Journal:  Biol Psychol       Date:  2011-10-24       Impact factor: 3.251

3.  Prefrontal cortex activity during response inhibition associated with excitement symptoms in schizophrenia.

Authors:  Yukika Nishimura; Ryu Takizawa; Miya Muroi; Kohei Marumo; Masaru Kinou; Kiyoto Kasai
Journal:  Brain Res       Date:  2010-11-05       Impact factor: 3.252

Review 4.  The reduced neuropil hypothesis: a circuit based model of schizophrenia.

Authors:  L D Selemon; P S Goldman-Rakic
Journal:  Biol Psychiatry       Date:  1999-01-01       Impact factor: 13.382

5.  Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory.

Authors:  Bram B Zandbelt; Mariët van Buuren; René S Kahn; Matthijs Vink
Journal:  Biol Psychiatry       Date:  2011-09-08       Impact factor: 13.382

6.  Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable.

Authors:  Jared X Van Snellenberg; Ivan J Torres; Allen E Thornton
Journal:  Neuropsychology       Date:  2006-09       Impact factor: 3.295

7.  Modeling conflict and error in the medial frontal cortex.

Authors:  Andrew R Mayer; Terri M Teshiba; Alexandre R Franco; Josef Ling; Matthew S Shane; Julia M Stephen; Rex E Jung
Journal:  Hum Brain Mapp       Date:  2011-10-05       Impact factor: 5.038

8.  Repetitive transcranial magnetic stimulation reveals abnormal plastic response to premotor cortex stimulation in schizophrenia.

Authors:  Tom Oxley; Paul B Fitzgerald; Timothy L Brown; Anthony de Castella; Z Jeff Daskalakis; J Kulkarni
Journal:  Biol Psychiatry       Date:  2004-11-01       Impact factor: 13.382

9.  Transcallosal inhibition in patients with callosal infarction.

Authors:  Jie-Yuan Li; Ping-Hong Lai; Robert Chen
Journal:  J Neurophysiol       Date:  2012-11-07       Impact factor: 2.714

10.  A case for motor network contributions to schizophrenia symptoms: Evidence from resting-state connectivity.

Authors:  Jessica A Bernard; James R M Goen; Ted Maldonado
Journal:  Hum Brain Mapp       Date:  2017-06-12       Impact factor: 5.038

View more
  2 in total

1.  Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders.

Authors:  Rebekka Lencer; Li Yao; James L Reilly; Sarah K Keedy; Jennifer E McDowell; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; Brett A Clementz; Su Lui; John A Sweeney
Journal:  Hum Brain Mapp       Date:  2018-09-10       Impact factor: 5.038

Review 2.  [The sensorimotor domain in the research domain criteria system: progress and perspectives].

Authors:  Dusan Hirjak; Stefan Fritze; Georg Northoff; Katharina M Kubera; Robert Christian Wolf
Journal:  Nervenarzt       Date:  2021-06-11       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.